These in vivo results were consistent with the in vitro cancer stem cell data using LLL12, indicating that LLL12 is a potent STAT3 inhibitor in the suppression of tumor growth of breast cancer stem-like cells in the mouse model in vivo. Here, STAT3 is linked to cancer.